Results 21 to 30 of about 69,806 (216)

Interventions for neurocognitive dysfunction [PDF]

open access: yes, 2017
Purpose of review: To evaluate current barriers to HIV cure strategies and interventions for neurocognitive dysfunction with a particular focus on recent advancements over the last three years. Recent findings: Optimal anti-retroviral therapy (ART) poses
Brew, B, Ellero, J, Lubomski, M
core   +2 more sources

Bilateral lower limb gangrene due to HIV vasculitis – a rare case

open access: yesSri Lankan Journal of Infectious Diseases, 2017
Human immunodeficiency virus (HIV) positive patients may develop vasculitis, either mediated by immunological factors or by direct vascular injury. It may also be caused by infectious agents or by some nonspecific causes.
D. Majumdar   +6 more
doaj   +1 more source

Patentes farmacêuticas e saúde pública: desafios à política brasileira de acesso ao tratamento anti-retroviral Pharmaceutical patents and public health: challenges for the Brazilian antiretroviral treatment policy

open access: yesCadernos de Saúde Pública, 2008
O preço elevado de medicamentos patenteados tem intensificado o debate em torno do impacto do regime da propriedade intelectual sobre o acesso a tratamentos de saúde, merecendo destaque o caso do HIV/AIDS.
Constance Marie Milward de Azevedo Meiners
doaj   +1 more source

Cost variation analysis of various brands of anti-retroviral agents currently available in Indian market: an economic perspective study

open access: yesInternational Journal of Basic & Clinical Pharmacology, 2022
Background: The aim was to analyze the percentage cost variations among different brands of the commonly prescribed anti-retroviral agents in the treatment of human immunodeficiency virus.Methods: The cost of different brands of commonly used Anti-Retroviral agents was sorted out by referring latest Indian drug index online, drug today, current index ...
Anusha R., Geetha A.
openaire   +1 more source

Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents—A Mini Review

open access: yesPharmaceuticals, 2023
The human immunodeficiency virus (HIV) is the primary cause of acquired immune deficiency syndrome (AIDS), one of the deadliest pandemic diseases. Various mechanisms and procedures have been pursued to synthesise several anti-HIV agents, but due to the ...
Mustapha Suleiman   +8 more
doaj   +1 more source

Electrolyte imbalance and sleep problems during anti-retroviral therapy: an under-recognized problem [PDF]

open access: yesSleep Science
Human immunodeficiency virus (HIV) infection, and the anti-retroviral therapy (ART) associated complications necessitate that the medical care system keeps evolving for proper management of this group of patients.
Md Dilshad Manzar   +7 more
doaj   +1 more source

Profile of anti-retroviral agents use in Colombia

open access: yesBiomédica, 2018
Introducción. La infección por VIH es una pandemia para la que actualmente existe tratamiento farmacológico que puede controlarla y prolongar la expectativa de vida del paciente.Objetivo. Determinar los patrones de prescripción de fármacos antirretrovirales en una población de personas afiliadas al régimen contributivo del Sistema General de Seguridad ...
Machado-Alba, Jorge E.   +2 more
openaire   +5 more sources

Inhibition of oncogenic transcription factor REL by the natural product derivative calafianin monomer 101 induces proliferation arrest and apoptosis in human B-lymphoma cell lines [PDF]

open access: yes, 2015
Increased activity of transcription factor NF-κB has been implicated in many B-cell lymphomas. We investigated effects of synthetic compound calafianin monomer (CM101) on biochemical and biological properties of NF-κB.
Chennamadhavuni, Spandan   +4 more
core   +2 more sources

A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use [PDF]

open access: yesBMC Infectious Diseases, 2013
Many HIV patients receiving antiretroviral treatment develop lipodystrophy. NEW-FILL® is a polylactic acid injected to treat facial lipoatrophy. The objectives of this study were to describe (1) change in quality of life (QoL) of HIV patients treated with NEW-FILL® in the management of facial lipoatrophy; (2) efficacy of NEW-FILL® using facial ...
Duracinsky, Martin   +5 more
openaire   +2 more sources

Dependence of АRT efficiency from the infection route in HIV infected patients

open access: yesZaporožskij Medicinskij Žurnal, 2017
The most rapid growth rate of the epidemic process of HIV in Ukraine is observed among injection drug users (IDUs). Substitution maintenance therapy (SMT) with methadone and buprenorphine significantly increases the patients’ maintenance in treatment due
D. H. Zhyvytsia, V. H. Kazeka
doaj   +1 more source

Home - About - Disclaimer - Privacy